Previous 10 | Next 10 |
2023-09-22 15:00:17 ET More on the markets No Signs Of A Major Top Yet, Staying Long BofA strategists have changed their view of the S&P 500 target, up 4%. Quant stock news sentiment measure keeps improving - BofA Amazon, Disney, Boeing boosted in Wells F...
2023-09-21 14:37:38 ET More on Novavax Novavax updated COVID shot to be reviewed by FDA 'expeditiously' Novavax updated COVID vaccine ready for US distribution Novavax: The Short Squeeze Story Isn't A Complete No-Brainer Novavax: Sell A Covid Bounce P...
2023-09-21 12:19:03 ET Summary Novavax, Inc. stock has been facing a downward spiral, but there may be a short-term trading opportunity if FDA approval for its COVID-19 vaccine is positive. The high level of short interest in Novavax makes a short squeeze a possibility. Novava...
2023-09-21 07:30:00 ET Moderna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had a lot to say. Today, everyone knows the company for its blockbuster COVID-19 vaccine -- it's only product. But in the coming five years, Moderna aims to launch...
2023-09-20 11:55:57 ET More on Health Care Sector: Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecutiv...
2023-09-19 05:30:00 ET It's best not to go all in on high-risk stocks, but that doesn't mean you should avoid them entirely. If you can tolerate some risk, certain players could make a good addition to a diversified portfolio. That's because, along with the risk, these companies also of...
2023-09-18 11:06:14 ET Pfizer expects roughly 24% of the US population that is eligible to receive updated COVID-19 vaccinations will actually get the shot, amounting to around 82M people, according to reports. Pfizer CFO David Denton delivered the estimate at the JP Morgan US All Stars...
2023-09-17 12:00:54 ET The impact of COVID, flu, and RSV on U.S. and U.K. hospitals is expected to be lower this winter compared to last, as there won't be a significant overlap between peak outbreaks of infections, the London-based data analytics firm Airfinity said in a recent report. ...
2023-09-15 15:00:00 ET More on the markets Key Region Of Support Sides With SPY Bullish Case Market Crosswinds And Nasdaq Looking Better Than Dow The Fed's rate-hike cycle has 'most assuredly ended' -- Lawrence Fuller Fund managers finally embrace U.S. stocks...
2023-09-14 16:56:27 ET More on Moderna, Pfizer, etc. Moderna wins EU recommendation for updated COVID shot Barclays projects over $5B COVID booster sales in fall 2023 Pfizer Vs. Gilead Sciences: COVID-19 Battle Of Pharma Titans Moderna sees $10B – $15B...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...